Faeth Therapeutics
FTH
42 hedge funds and large institutions have $8.21M invested in Faeth Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
14% more funds holding
Funds holding: 37 → 42 (+5)
0.45% more ownership
Funds ownership: 11.13% → 11.58% (+0.45%)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
58% less capital invested
Capital invested by funds: $19.7M → $8.21M (-$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$331K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$200K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$151K |
| 4 |
Two Sigma Investments
New York
|
+$133K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$91.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$149K |
| 2 |
BlackRock
New York
|
-$138K |
| 3 |
Morgan Stanley
New York
|
-$102K |
| 4 |
VF
Virtu Financial
New York
|
-$93K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$74K |
FTH Hedge Fund Activity: Q1 2022 in Review
42 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q1 2022, worth a combined $8.21M — down 58% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FTH positions and 6 closed out — a net gain of 5 holders — while 9 added to existing stakes and 15 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $331K. The largest seller was Millennium Management, cutting an estimated $149K.
- 42 institutional investors held Faeth Therapeutics (FTH) as of Q1 2022, up from 37 in Q4 2021.
- Funds reported $8.21M of Faeth Therapeutics stock for Q1 2022, down 58% quarter-over-quarter.
- 11 funds opened new Faeth Therapeutics positions in Q1 2022 and 6 closed out, a net change of +5 holders.
- The largest Faeth Therapeutics buyer in Q1 2022 was Renaissance Technologies, an estimated $331K added.
- The largest Faeth Therapeutics seller in Q1 2022 was Millennium Management, an estimated $149K sold.
Based on aggregated 13F filings for Q1 2022.